Clinical and genetic predictors of anti-platelet therapy selection in coronary artery disease patients undergoing percutaneous coronary intervention
Nicholas Varunok, M.D. Candidate1, Kasey Hamrick, Pharm.D. Candidate2, Melissa Polasek, Pharm.D.2, John Andrew Lee, Pharm.D.2, Mr. Michael Wells, PharmD Candidate3, Alexandra Cervantes, Pharm.D. Candidate2, Vindhya B. Sriramoju, M.D.1, Lucius Howell, M.D.1, George A. Stouffer, M.D.1 and Craig Lee, Pharm.D., Ph.D., FCCP2
1Division of Cardiology, UNC School of Medicine, Chapel Hill, NC
2Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, Chapel Hill, NC
3UNC Eshelman School of Pharmacy